Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Hartmann

Showing results (1-10 of 265) with videos related to

Pageof 27
Sort By:
Neuro-Oncology|August 8, 2018
Inclusion bias of patients with genetically different glioblastoma subgroups in clinical trialsChristian Hartmann
Ugeskrift for Laeger|April 2, 2002
[Molecular targeted treatment of hematological diseases with monoclonal antibodies and tyrosine kinase inhibitors. The Danish Society of Hematology]Christian Hartmann Geisler
Ugeskrift for Laeger|April 19, 2005
[Chronic lymphatic leukemia: primary treatment based on biological risk stratification. Danish Society of Hematology]Christian Hartmann Geisler
Ophthalmology|September 18, 2003
Postoperative wound dehiscenceUwe Pleyer, Christian Hartmann
Pathologie (Heidelberg, Germany)|June 20, 2025
[The biomarker MGMT (O<sup>6</sup>-methylguanine-DNA methyltransferase) in tumor pathology]Christian Hartmann, Ulrich Lehmann
Acta Neurochirurgica|January 18, 2017
The new WHO 2016 classification of brain tumors-what neurosurgeons need to knowRouzbeh Banan, Christian Hartmann
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|March 27, 2009
Molecular pathology of oligodendroglial tumorsChristian Hartmann, Andreas von Deimling
Journal of Child Neurology|October 21, 2009
Histology and molecular pathology of pediatric brain tumorsStefan Pfister, Christian Hartmann, Andrey Korshunov
Expert Review of Neurotherapeutics|December 6, 2006
Diagnostic and molecular pathology of meningiomasChristian Hartmann, Jan Boström, Matthias Simon
Journal of Cataract and Refractive Surgery|April 17, 2002
Long-term endothelial cell loss after phacoemulsification: peribulbar anesthesia versus intracameral lidocaine 1%: prospective randomized clinical trialTim Heuermann, Christian Hartmann, Norbert Anders
Pageof 27

Showing results (1-10 of 265) with videos related to

Sort By:
Pageof 27
Neuro-Oncology|August 8, 2018
Inclusion bias of patients with genetically different glioblastoma subgroups in clinical trialsChristian Hartmann
Ugeskrift for Laeger|April 2, 2002
[Molecular targeted treatment of hematological diseases with monoclonal antibodies and tyrosine kinase inhibitors. The Danish Society of Hematology]Christian Hartmann Geisler
Ugeskrift for Laeger|April 19, 2005
[Chronic lymphatic leukemia: primary treatment based on biological risk stratification. Danish Society of Hematology]Christian Hartmann Geisler
Ophthalmology|September 18, 2003
Postoperative wound dehiscenceUwe Pleyer, Christian Hartmann
Pathologie (Heidelberg, Germany)|June 20, 2025
[The biomarker MGMT (O<sup>6</sup>-methylguanine-DNA methyltransferase) in tumor pathology]Christian Hartmann, Ulrich Lehmann
Acta Neurochirurgica|January 18, 2017
The new WHO 2016 classification of brain tumors-what neurosurgeons need to knowRouzbeh Banan, Christian Hartmann
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|March 27, 2009
Molecular pathology of oligodendroglial tumorsChristian Hartmann, Andreas von Deimling
Journal of Child Neurology|October 21, 2009
Histology and molecular pathology of pediatric brain tumorsStefan Pfister, Christian Hartmann, Andrey Korshunov
Expert Review of Neurotherapeutics|December 6, 2006
Diagnostic and molecular pathology of meningiomasChristian Hartmann, Jan Boström, Matthias Simon
Journal of Cataract and Refractive Surgery|April 17, 2002
Long-term endothelial cell loss after phacoemulsification: peribulbar anesthesia versus intracameral lidocaine 1%: prospective randomized clinical trialTim Heuermann, Christian Hartmann, Norbert Anders
Pageof 27